Sympathovagal Balance in Smoking Cessation

NCT01474265 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: Varenicline
DRUG: Placebo
DRUG: Nicorette TX

Sponsor

Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

Collaborators

[object Object]